AbbVie · 6 days ago
Director, Enterprise AI Strategy & Operations
AbbVie is a company dedicated to discovering and delivering innovative medicines and solutions for serious health issues. The Director of Enterprise AI Strategy and Operations will lead the development and execution of AbbVie’s enterprise AI strategy, collaborating with cross-functional leaders to enhance AI initiatives and drive operational excellence.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Enterprise AI Strategy: Develop and execute enterprise AI strategy, partnering with Director II to ensure alignment with AbbVie’s business objectives
Functional and Business Unit AI Strategies: Support functional and business unit leaders in developing and continually refreshing their AI strategies, incorporating the latest innovations in AI and identifying opportunities where AI can help accelerate strategic business priorities
External AI Advisory Board: Oversee AbbVie’s external AI advisory board, co-leading across functions and BUs to collate key topics and questions for advisory board meetings, gathering key insights to be applied throughout enterprise and functional/BU AI strategies with senior leadership
Deep AI Expertise: Apply expertise in Machine Learning, Generative AI, Agentic AI, and Physical AI to contribute to innovative solutions for biopharma applications
Operational Excellence: Assist in establishment and execution of operational frameworks and governance, ensuring cross-functional communication and integration across business units
Measurement and Reporting: Monitor, analyze, and report on the progress and impact of AI initiatives
Team Leadership / People Management: Lead teams through ambiguity and change, inspiring resilience and continuous improvement
Support Cross-Cutting Enablers: Provide thought leadership and support in cross-cutting capabilities including but not limited to technology enablement, responsible AI, and data readiness
Qualification
Required
Degree fields: Computer Science, Statistics, AI/ML, Physics, Math, Chemistry, Bioinformatics, Computational Biology, or similar
Bachelor's: 10+ years in strategy including 3+ years of work at a life sciences, big tech, start-ups, or a top consulting firm, OR
Master's: 9+ years in strategy including 3+ years of work at a life sciences, big tech, start-ups, or a top consulting firm, OR
PhD: 5+ years in strategy including 3+ years of work at a life sciences, big tech, start-ups, or a top consulting firm
Broad understanding of emerging technologies in AI/ML
Effective project management and teamwork skills, with the ability to communicate across multiple management levels and thrive in cross-functional settings
Key competencies: Knowledge of AbbVie's business, experience in AI/ML, enterprise thinking with ability to build credibility within the organization; time management, project management mastery, strong interpersonal skills (i.e. communication adaptability, meeting facilitation, negotiation, mediation, conflict management), and ability to successfully adapt to changing requirements
Preferred
Advanced degree in a computational field
Professional experience at a product-focused technology company (e.g., Big Tech, start-ups)
Manager role and above at a top consulting firm
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Long-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase